secwatch.observer — SEC 8-K summary
======================================

Issuer:     REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH)
CIK:        0001742927
Form:       8-K
Filed at:   2026-01-23T23:59:59+00:00
Accession:  0001437749-26-001913
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 3.01, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Reviva gets Nasdaq extension to March 27, 2026 for minimum bid price rule compliance
--------------------------------------------------------------------------------

- Nasdaq Panel granted exception through March 27, 2026 to regain compliance with $1.00 minimum bid price.
- Company requested hearing after delisting determination on Nov 11, 2025; hearing held Jan 8, 2026.
- To regain compliance, closing bid price must be at least $1.00 for 10 consecutive business days.
- Company may implement reverse stock split if needed; warns split may not maintain price increase.
- Risk of delisting remains if unable to meet deadline or other Nasdaq listing requirements.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1742927/000143774926001913/0001437749-26-001913-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1742927/000143774926001913/rvph20260122_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-001913

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer